Expression and function of FGF-4 in peri-implantation development in mouse embryos by Rappolee, Daniel A. et al.
Wayne State University
DigitalCommons@WayneState
Department of Obstetrics and Gynecology
Research Publications
C.S. Mott Center for Human Growth and
Development
1-1-1994
Expression and function of FGF-4 in peri-
implantation development in mouse embryos
Daniel A. Rappolee
Northwestern University, drappole@med.wayne.edu
Claudio Basilico
New York University
Yogesh Patel
Northwestern University
Zena Werb
University of California
This Article is brought to you for free and open access by the C.S. Mott Center for Human Growth and Development at
DigitalCommons@WayneState. It has been accepted for inclusion in Department of Obstetrics and Gynecology Research Publications by an
authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Rappolee D. A., Basilico, C., Patel, Y., and Werb, Z. 1994. Expression and function of FGF-4 in peri-implantation development in
mouse embryos. Development. 120, 2259-2269.
Available at: http://digitalcommons.wayne.edu/med_obgyn/4
 INTRODUCTION
Fibroblast growth factors (FGFs) are small polypeptides that
mediate embryonic induction in vertebrates. FGFs are
important mediators of mesoderm induction in Xenopus and
chick and of limb development in mouse and chick (Rappolee
and Werb, 1994; Niswander and Martin, 1992, 1993a,b; Vogel
and Tickle, 1993). There are nine members of the FGF family
(Hebert et al., 1990; Basilico and Moscatelli, 1992). In the
present terminology, acidic FGF is FGF-1, basic FGF is FGF-
2, int-2 is FGF-3, Kaposi’s sarcoma-type FGF is FGF-4 and
keratinocyte growth factor is FGF-7; the other members are
FGF-5, FGF-6, FGF-8 and FGF-9 (Basilico and Moscatelli,
1992; Tanaka et al., 1992; Miyamoto et al., 1993). Several
members of the FGF family can induce mesoderm and markers
for posterior mesoderm in animal cap preparations from
Xenopus embryos (Kimelman and Kirschner, 1987; Ruiz i
Altaba and Melton, 1989; Paterno et al., 1989). In whole frog
embryos, overexpression of FGF induces anterior and posterior
mesoderm (Kimelman and Maas, 1992). Expression of a
dominant negative FGF receptor disrupts posterior/ventral
mesoderm and the expression of brachyury in Xenopus (Amaya
et al., 1991, 1993).
The role of FGF in early stages of mammalian development
has not been well studied. Null mutants for FGF-3 have fewer
vertebrae in the tail as well as other mutant phenotypes
occurring later in development (Mansour et al., 1993). FGF-3,
FGF-4 and FGF-5 are expressed at gastrulation (Hebert et al.,
1990; Wilkinson et al., 1988; Niswander and Martin, 1992) in
the day 7.0 post coitum (p.c.) mouse. At day 4.5 p.c., the inner
cell mass (ICM) of the preimplantation mouse blastocyst
contains FGF-4 mRNA (Niswander and Martin, 1992) but not
FGF-2 (Rappolee et al., 1988). FGF-4 and FGF-3 are inversely
regulated in embryonal carcinoma cells (Hebert et al., 1990;
Velcich et al., 1989); that is, undifferentiated embryonal
carcinoma stem cells express FGF-4 but not FGF-3, and dif-
ferentiated cells (resembling parietal endoderm) express FGF-
3 but not FGF-4. 
FGF action is mediated through the cooperative interaction
of a high-affinity FGF receptor and a requisite low-affinity
FGF receptor, such as the heparan sulfate proteoglycan
syndecan protein (Klagsbrun and Baird, 1991). There are four
members of the family of high-affinity receptors for FGF
(Dionne et al., 1990; Lee et al., 1989; Keegan et al., 1991;
Partanen et al., 1991, 1992; Johnson et al., 1991). Expression
of high-affinity FGF receptors during mouse development has
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One of the earliest events in mammalian embryogenesis is
the formation of the inner cell mass (ICM) and the subse-
quent delamination of primitive endoderm. We have found
that mRNA for fibroblast growth factor (FGF)-4, but not
FGF-3, is expressed in preimplantation mouse blastocysts
and that the FGF-4 polypeptide is present in ICM cells.
ICM-like embryonal carcinoma cells and embryonic stem
cells also express FGF-4. Conversely, differentiated
embryonal carcinoma cells in the endoderm lineage express
FGF-3, but not FGF-4 mRNA.
Although mouse embryos expressed FGF-4 mRNA from
the 1-cell stage, embryos cultured from the 2-cell through
the blastocyst stage in the presence of recombinant FGF-4
did not respond mitogenically. However, when ICMs that
were isolated by immunosurgery were cultured with FGF-
4, the number of morphologically distinct, differentiated
parietal endoderm cells growing out onto the coverslip
increased, without an increase in the number of undiffer-
entiated ICM cells. ICM outgrowths cultured with FGF-4
increased their secretion of 92×103 Mr gelatinase and tissue
plasminogen activator, a hallmark of migrating cells.
Receptors for FGF-4 (FGFR-3 and FGFR-4) are expressed
in all cells of the mouse blastocyst. These findings indicate
that FGF-4 produced by undifferentiated ICM cells acts in
the peri-implantation period of embryogenesis to influence
the production and behavior of endoderm cells derived
from them.
Key words: fibroblast growth factor, mouse embryogenesis,
metalloproteinase, blastocyst, tissue plasminogen activator, RT-PCR
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been investigated in postimplantation embryos but not in
preimplantation embryos (Orr-Urtreger et al., 1991). FGF
receptor (FGFR)-2 is expressed in the primitive ectoderm of
day 5.5 p.c., and FGFR-1 is expressed in the primitive streak
during gastrulation (Orr-Urtreger et al., 1991; Yamaguchi et
al., 1992). Syndecan-1, a heparan sulfate proteoglycan, is
expressed in mouse preimplantation and postimplantation
embryos (Sutherland et al., 1991).
To define the role of FGF-4 in the earliest stages of mouse
embryogenesis, we assayed the temporal expression of FGF-4
and FGF-3 mRNA in preimplantation mouse embryos. We also
localized the FGF-4 polypeptide in ICM cells and determined
some effects of FGF-4 expression at this stage of development.
Transcripts for two of the four high-affinity FGF receptors
were detected in all cells of the mouse blastocyst.
MATERIALS AND METHODS
Materials 
Amplitaq DNA polymerase was purchased from Perkin-Elmer Cetus
(Norwalk, CT). Restriction enzymes and T4 polynucleotide kinase
were purchased from New England BioLabs (Beverly, MA) and
Gibco/BRL (Gaithersburg, MD). Radioisotopes were obtained from
New England Nuclear (Boston, MA). Moloney murine leukemia virus
(MMLV) reverse transcriptase and Superscript MMLV reverse tran-
scriptase were obtained from Gibco/BRL. Polymerase chain reaction
(PCR) oligonucleotides were obtained from the University of Cali-
fornia-San Francisco (UCSF) Biomolecular Resource Center or were
synthesized in our laboratory on an Applied Biosystems PCR-Mate
oligosynthesizer (Foster City, CA). Recombinant human FGF-4 and
anti-FGF-4 polyclonal antibodies were produced as described by C.
Basilico in collaboration with Genetics Institute (Bellosta et al.,
1993).
Mouse eggs and embryos 
Standard techniques were used for obtaining eggs and zygotes (Hogan
et al., 1986). Female CD-1 or CF-1 mice (6-10 weeks old, Charles
River Laboratories, Wilmington, MA) were injected with 10 i.u. of
pregnant mares’ serum gonadotropin (Equitech, Kerrville, TX),
followed by an injection of 5 i.u. of human chorionic gonadotropin
(Serono, Randolph, MA) 44-48 hours later. After the second injection,
females were housed overnight with C57BL/6J × SJL/J F1 hybrid
males (Jackson Laboratories, Bar Harbor, ME). Embryos were
obtained at the following stages: 1-cell (12 hours p.c.), 2-cell (36
hours p.c.), 4-cell (48 hours p.c.), 8-cell (60 hours p.c.) and blastocyst
(84-96 hours p.c.). 1-cell to 8-cell embryos were flushed from the
oviducts of superovulated females and later embryos were dissected
from the uteri of females (6.0, 7.5 or 8.5 days of gestation). Embryos
were flushed from the uteri or oviducts of mice with flushing medium-
I (FM-I) (Spindle, 1980) containing 3 mg/ml of bovine serum
albumin. The embryos were then washed through 6 drops of FM-I.
For isolation of ICMs, immunosurgery to remove trophectoderm was
performed according to the method of Solter and Knowles (1975). All
eggs and embryos were sorted and freed of debris under a dissecting
microscope.
RNA preparation 
A microadaptation (Rappolee et al., 1988, 1989) of the guanidine
isothiocyanate (GuSCN)-CsCl gradient ultracentrifugation technique
was used to prepare total RNA from 100-200 embryos (Chirgwin et
al., 1979). Embryos flushed from the genital tract at specific stages or
cultured to specific stages were washed though 6 drops of FM-I, sol-
ubilized in 100 µl of GuSCN containing 20 µg of Escherichia coli
rRNA (Boehringer Mannheim, Indianapolis, IN), layered over 100 µl
of 5.7 M CsCl, and centrifuged for 2 hours at 80,000 revs/minute in
a TL-100A rotor in a Beckman TL-100 benchtop ultracentrifuge.
Yields of RNA were based on carrier amount and ranged from 35%
to 80%. RNA used for positive controls was isolated from P388D1
macrophages or from retinoic acid-treated F9 teratocarcinoma cells,
as described previously (Rappolee et al., 1988; Brenner et al., 1989).
The concentration of RNA was determined by measurement of
absorbance at 260 nm.
Reverse transcription-polymerase chain reaction (RT-
PCR) 
RT-PCR was performed essentially as described previously
(Rappolee et al., 1988, 1989, 1992; Hahnel et al., 1990) with the use
of the oligonucleotide primers shown in Table 1. Briefly, RNA was
reverse-transcribed with 100 units of MMLV reverse transcriptase or
Superscript MMLV reverse transcriptase primed with 0.2 µg of
random hexanucleotides (Pharmacia, Piscataway, N.J.) or 0.5 µg of
12- to 18-mer oligo(dT) (Bethesda Research Laboratories) in a 20 µl
mixture. In early studies on FGF expression, reaction mixtures were
heat-denatured and flash-cooled; 50 additional units of buffered
Superscript MMLV was added and the reaction mixture was reincu-
bated. The proportion of the reaction mixture that was equivalent to
10 embryos was added to sequence-specific primed PCR reaction
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Table 1. Oligonucleotide primers used for RT-PCR
Amplified RT-PCR Diagnostic
Primer sequences length threshold restriction
Gene (position in sequence) (bp) RNA source enzyme
FGF-3a 5′ GTGCGGCTGCTGCAGAGTAGCCA 204 10 pg, BalI
FGF-3 3′ CTGGAGTTGGTCTCAGAGGGCTT F9
(5′, 5887-5909; 3′, 6078-6090) differentiated
FGF-4b 5′ CCGGTGCAGCGAGGCGTGGT 255 10 pg, HaeIII
FGF-4 3′ GGAAGGAAGTGGGTGACCTTCAT F9
(5′, 958-977; 3′, 1618-1640) undifferentiated
LIFc 5′ AAGTTGGTGGAGCTGTATCGGATG 236 10 pg, SmaI
LIF 3′ GGCTTCTTTGTCAGAGTGGTCGGG P388D1
(5′, 319-342; 3′, 526-549)
Brachyuryd 5′ CTAGCCAGTATCCCAGTCTCTGG 198 100 pg, SmaI
Brachyury 3′ GACTGTAGCCCCTTCATACAT 7.5 dg
(5′, 1139-1161; 3′, 1312-1336) embryo
Actine 5′ CGTGGGCCGCTCTAGGCACCA 243 10 pg, BglII
Actin 3′ TTGGCCTTAGGGTTCAGGGGGG Balb/c3T3
(5′, 23-43; 3′, 245-266)
References: aDickson and Peters, 1987; bRappolee et al., 1988; cGearing et al. 1988; dHerrman et al., 1988, and eRappolee et al., 1988.
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mixture in a buffer containing 10 mM Tris-HCl (pH 8.3), 600 µM
each dNTP, 5 µM trimethyl ammonium chloride (Sigma Chemical
Co., St. Louis, MO), and 4.0 mM MgCl2 in a 50 litre reaction mixture
(Rappolee et al., 1988). 2 µm of embryonic stem cell or F9 terato-
carcinoma cell RNA was reverse-transcribed, and one tenth of the
reaction mixture (or a 10-fold dilution series of it) was amplified by
PCR. The mixture was overlaid with 100 µl of mineral oil and
amplified for 60 cycles on a Perkin-Elmer Cetus Thermocycler pro-
grammable heating block. The PCR fragments were separated on a
4% agarose gel (3% GTG/1% Seakem, FMC Corp., Rockland, ME)
and visualized by ethidium bromide staining. Gels were photographed
with a Polaroid MP-4 camera and negative images were reversed for
clarity of presentation. Fragments were verified by size and restric-
tion enzyme mapping (Brenner et al., 1989). For restriction enzyme
analysis, the fragments were precipitated with ammonium acetate
directly from the PCR reaction mixture, washed twice with 70%
ethanol and digested according to the restriction enzyme manufac-
turer’s instructions.
Embryo culture 
For each analysis, 30-40 embryos were cultured from the 2-cell to the
blastocyst stage in CZB medium (Chatot et al., 1989) or in TE
medium at 10 embryos per 20 µl drop (Spindle, 1980) under paraffin
oil (Aldrich, Milwaukee, WI). ICMs were isolated from expanded
blastocysts (4.5 day p.c.) by immunosurgery (Solter and Knowles,
1975) and cultured on glass or on coverslips coated with fibronectin.
For determination of cell number in embryos, ICMs were cultured for
3 days with or without FGF-4. For assay of metalloproteinases, ICMs
were cultured for 3 days with 10−8 M FGF-4. All experiments were
performed at least twice.
Cell culture 
Embryonal carcinoma F9 cells, obtained from the UCSF Cell Culture
Facility, were cultured on gelatin (Sigma)-coated culture dishes in
Dulbecco’s modified Eagle’s medium containing 10% heat-inacti-
vated fetal bovine serum. D3 embryonic stem cells (Alexander and
Werb, 1992) were cultured on 0.1% gelatin-coated dishes as described
by Robertson (1987). For collection of conditioned medium for
sodium dodecyl sulfate (SDS)-substrate gel analysis, the confluent
cell cultures were incubated in serum-free medium for 24 hours.
Medium conditioned by rabbit synovial fibroblasts stimulated to
secrete proteinases was obtained as described previously (Unemori
and Werb, 1988).
Endoderm differentiation of embryonal carcinoma and
embryonic stem cells 
Undifferentiated F9 teratocarcinoma cells (5×105), which resemble
undifferentiated ICM cells, were seeded onto gelatin-coated 10-cm
tissue culture dishes and cultured for up to 6 days with or without
5×10−7 M retinoic acid, 10−4 M or 10−3 M dibutyryl cAMP, and 5
mM isobutylmethylxanthine in Dulbecco’s modified Eagle’s medium
containing 10% calf serum (Strickland et al., 1980; Solter et al., 1979;
Hogan et al., 1986). We used this procedure to obtain cells that
resemble the parietal endoderm, which are progeny cells of the
primitive endoderm (Strickland et al., 1980; Hogan et al., 1986).
Embryonic stem cells were differentiated to endoderm by removal of
leukemia inhibitory factor (LIF), aggregation, and readherence as
described previously (Robertson, 1987).
Indirect immunocytochemistry and nuclear staining 
For immunocytochemical analysis, blastocysts were either fixed in
solution without centrifugation or centrifuged onto poly-L-lysine-
coated coverslips in a Shandon (White Plains, NY) cytocentrifuge at
900 revs/minute for 30 minutes and fixed in 2% paraformaldehyde
(pH 7.2) in phosphate-buffered saline. The blastocysts were stained
with rabbit polyclonal anti-human FGF-4 antibody (diluted at 1:200).
For specificity controls, 0.5 µg of diluted anti-human FGF-4 antibody
was absorbed with human FGF-4. The primary antibody was followed
by staining with biotinylated anti-rabbit IgG and then by Texas Red-
labeled streptavidin as described previously (Rappolee et al., 1988).
Alternatively, streptavidin-alkaline phosphatase was used on whole
unattached blastocysts as described above, but all fixation and per-
meabilization steps were performed in solution. This was done to
maintain morphology of the blastocyst to identify the cells express-
ing FGF-4 antigen. An insoluble product was developed by using
bromo-chloro-indolyl phosphate and nitroblue tetrazolium (Vector,
Burlingame, CA). Embryos fixed and stained in solution were viewed
in rectangular microcapillary tubes (Vitro Dynamics, Passaic, NJ). All
photography was performed with a Zeiss Photomicroscope III and
water immersion 25× or 63× phase Plan-Neofluor lenses, and Tri-X
film was exposed and developed under similar lighting conditions.
To determine the response of embryos to FGF, FGF-4 was serially
diluted in 100 µl volumes and added at appropriate concentrations
with 20 2-cell embryos in 20 µl droplets under oil and cultured for 3
days; blastocysts were then fixed onto glass coverslips and stained.
For staining of nuclei, embryos were fixed in solution by 3:1
(vol/vol) ethanol-glacial acetic acid on coverslips and incubated in 1
µg/ml of Hoechst 33258 in water for 5 minutes and destained
overnight (Handyside and Hunter, 1984). Nuclei were counted and
photographed as described above.
Zymography of proteinases on SDS-substrate gels 
To determine whether extracellular matrix-degrading proteinases
were secreted during mouse embryogenesis, immunosurgically
isolated ICMs were cultured for 24-72 hours in T+2xAA medium
(Spindle, 1980) or RPMI medium containing lactalbumin
hydrolysate in the presence or absence of 10−8 M FGF-4. The con-
ditioned medium was then analyzed by zymography, as described
previously (Unemori and Werb, 1988). Briefly, conditioned medium
(5-20 µl) was diluted with 4× SDS sample buffer without 2-mercap-
toethanol and then loaded onto 10% or 12% SDS-polyacrylamide
gels containing 1 mg/ml of either gelatin or casein and 10 µg/ml
human plasminogen, as described previously (Brenner et al., 1989;
Behrendtsen et al., 1992). After electrophoresis the gels were washed
2 times for 15 minutes each time in 2.5% Triton X-100 (Sigma) and
incubated for 24 to 48 hours at 37˚C in 350 mM Tris-HCl buffer (pH
7.6) containing 10 mM CaCl2. Gels were then stained in Coomassie
Blue R250, followed by destaining. Clear bands indicate the presence
of proteinases. For quantification of proteinases, negatives of gels
were scanned with a Pharmacia scanning densitometer and peaks
were plotted with the Cricket graph program on a Macintosh IIsi
computer.
In situ hybridization 
Amplimers of FGFR-1-4 receptors and syndecan-1 (Rappolee et al.,
unpublished data) were cloned into PcrII vectors according to the
manufacturer’s protocols (Invitrogen). The identity of the amplimer
was verified by restriction analysis at two diagnostic sites, and some
were sequenced (Rappolee et al., 1988). Amplimers for FGFR-4,
FGFR-3, and syndecan-1 were derived from sequences in the 3′
untranslated region. Digoxigenin cRNA was prepared from plasmid
DNA and treated with RNase-free DNase to remove the template
(Genius RNA labeling kit, Boehringer-Mannheim). 
Blastocysts were processed according to methods described below.
After collection, blastocysts were reinjected (within 30 minutes of
recovery from the uterus) into the oviduct for sectioning (Chapman
and Wolgemuth, 1993). For sectioning, the oviducts were fixed in 4%
paraformaldehyde buffered in neutral PBS overnight, dehydrated and
embedded in paraffin, and three 10 µm sections were made. After
dehydration the slides were air-dried and stored at −20˚C until use.
In situ hybridization was performed according to a modified
protocol of Harkey et al. (1992) (Rappolee et al. unpublished data).
Paraffin sections were dewaxed, rinsed in 100% ethanol and air dried.
Sections were rehydrated, washed in PBS containing 0.1% Tween 20
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(PBT) and treated with proteinase K (20 mg/ml in PBT). The pro-
teinase K was neutralized in glycine in PBS, washed with PBT,
refixed with 4% paraformaldehyde in PBS and washed in PBT. The
slides were prehybridized at 60˚C for 1 hour. Prehybridization
solution was removed and 10 µl of hybridization solution containing
100 ng of digoxigenin-labeled RNA probe was added; the slide was
hybridized at 50˚C in a humidified box overnight. All labeled probes
had a sensitivity of 20-100 fM by dot-blot hybridization. After hybrid-
ization the slides were washed at 50˚C in 50% PBT-50% prehy-
bridization solution in PBT at 50˚C, 1× SSC at 60˚C in PBT and
incubated with PBT containing 2% normal sheep serum to block non-
specific binding. Slides were incubated with 1:2000 dilution of anti-
digoxigenin-Ap conjugate in PBT-1% normal sheep serum and
washed in PBT and alkaline phosphatase buffer including levamisole
for 5 minutes. The color reaction was carried out until sufficient
product was visible. The reaction was stopped with PBT, slides were
stained with Hoechst 33258 (10 µg/ml in water), destained, dehy-
drated and mounted in medium (Tris-EDTA with NaN3), and the cov-
erslips were sealed with rubber cement (Harkey et al., 1992; Rappolee
et al., unpublished data). Photomicrography was done with a Nikon
Microphot-FXA microscope (Melville, NY). Micrographs were taken
with epifluorescence to detect Hoechst-stained nuclei (with a barrier
filter at 420 nm) or diascopic illumination to see color products, using
Kodak 200 DIN print film. Objectives were chosen to cover the field
for pertinent detail at 100× and 200× (Nikon Plan 10 and Plan 20
objectives, respectively). 
Statistical analysis 
The mean increase in
cell number of mouse
embryos cultured with
FGF-4 was compared
with that of control
embryos by Student’s t-
test on a Macintosh
computer with software
from Glantz (1992). 
RESULTS
FGF-4 mRNA
expression in
preimplantation
mouse embryos 
RT-PCR was per-
formed on 1-cell, 2-
cell, 8-cell and blas-
tocyst-stage mouse
embryos for analysis
of mRNA. FGF-4
was first detected at
the 1-cell stage and
increased in accumu-
lation through the
blastocyst stage.
After implantation,
FGF-4 mRNA was
expressed in 6- and
8.5-day mouse
embryos. RT-PCR
detected FGF-4 in as
little as 10 pg of
RNA in a dilution
series of whole RNA from undifferentiated F9 cells (Fig. 1A).
In contrast, FGF-3 mRNA was not detected in preimplanta-
tion mouse embryos, although it was detected by day 6 p.c.
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Table 2. Expression of mRNA for FGF-4 and FGF-3
during F9 cell differentiation
PCR products visualized during F9 cell differentiation state
mRNA
assayed F9 stem 4d RA 4d RA 4d RA 4d RA
(ng) cells 1d cAMP 2d cAMP 3d cAMP 4d cAMP 4d RA
Actin 200 + + + + + +
20 + + + + + +
2 + + + + + +
FGF-3 200 − + + + + +
20 − + + + + +
2 − + + + − −
FGF-4 200 + − − + + +
20 + − − − − −
2 + − − − − −
F9 teratocarcinoma cells were cultured alone or with retinoic acid (RA) and
cAMP as described in the text. ‘+’ indicates expression and ‘−’ indicates lack
of expression of PCR products as visualized by ethidium bromide staining. d,
days.
Fig. 1. FGF-4 mRNA is expressed from the 1-cell through the blastocyst stage. RNA from 100 embryos at each
stage was purified by a microadaptation of the GuSCN/CsCl technique, a first-strand synthesis of cDNA was made,
and one tenth of the mixture was amplified for 60 cycles in the PCR. Growth factors were detected in PCR
fragments by agarose gel electrophoresis. (A) FGF-4, (B) FGF-3, (C) LIF, (D) brachyury. Each lane of
preimplantation embryos represents the equivalent of 10 embryos. Day 6 p.c. represents a single embryo, and day
8.5 p.c. represents 0.25 embryo. M, molecular weight standards (1 kb ladder, BRL). Control RNA is shown in a
series of 10-fold dilutions beginning at the left with 100 ng of whole RNA. The sources of control RNA are (A)
undifferentiated F9 cells, (B) differentiated parietal endoderm-like F9 cells, (C) P388D1 macrophages, and (D) day
7.5 mouse embryos. Arrowheads indicate RT-PCR products of the following sizes: (A) 253 bp, (B) 204 bp, (C) 236
bp, and (D) 178 bp. 
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and continued to be expressed through day 8.5, and FGF-3
mRNA was detected in 10 pg of RNA from F9 cells differ-
entiated to parietal endoderm (Fig. 1B). These data extend
previous observations in which FGF-4 mRNA was detected
as early as the blastocyst stage (Niswander and Martin, 1992)
and FGF-3 polypeptide was detected in gastrulation-stage
(day 7 p.c.) embryos (Wilkinson et al., 1988). As a positive
control for the expression of a growth factor, we also deter-
mined the expression of mRNA for LIF, previously reported
in preimplantation mouse embryos (Murray et al., 1990;
Conquet and Brulet, 1990). LIF mRNA was expressed at all
stages of preimplantation mouse development (Fig. 1C).
Brachyury, a T locus gene associated with the initial induction
of mesoderm (Wilkinson et al., 1990; Herrmann et al., 1990),
was not detected before implantation but was detected in day
6 p.c. embryos (Fig. 1D), before overt mesoderm differen-
tiation (Tam and Beddington, 1987).
FGF-4 mRNA was expressed in undifferentiated F9 terato-
carcinoma stem cells, as previously reported (Velcich et al.,
1989; Hebert et al., 1990) but was not detected in the
immediate endodermal progeny of these cells; however, FGF-
4 mRNA was expressed again after continued culture of the
differentiated cells (Table 2). FGF-3 mRNA
was expressed only after differentiation of stem
cells into parietal endoderm cells induced by
retinoic acid and dibutyryl cAMP.
FGF-4 polypeptide expression in ICM
cells 
Mouse blastocysts that had been attached to
poly-L-lysine-coated coverslips by cytocen-
trifugation or fixed in solution were analyzed
immunocytochemically with a polyclonal
antibody to human FGF-4, which cross-reacts
with mouse FGF-4. FGF-4 polypeptide was
detected in ICM cells but not in trophectoderm
of mouse blastocysts by immunocytochemistry
(Fig. 2A,B,F). After preincubation of the anti-
FGF-4 antibody with excess recombinant FGF-
4, FGF-4 was no longer detected in ICM cells
(Fig. 2C,D). These data corroborate a previous
report of localized FGF mRNA in mouse ICM
cells (Niswander and Martin, 1992).
Effects of exogenous FGF-4 on
cultured preimplantation embryos 
To determine if FGF-4 affects the growth rate
of preimplantation embryos, we cultured 2-cell
embryos through the blastocyst stage in
medium alone or with recombinant FGF-4
(4.3×10−12-4.3×10−7 M) in a 10-fold dilution
series. In duplicate experiments, there was no
significant effect on cell number at the late
blastocyst stage (Fig. 3; P>0.05; Student’s t-
test). This lack of responsiveness of preim-
plantation embryos to exogenous FGF-4 was
paralleled by a lack of effect when endogenous
FGF-4 was reduced in 2-cell to blastocyst-
stage embryos by antisense FGF-4 oligonu-
cleotides (data not shown), even though
antisense insulin-like growth factor (IGF)-II
inhibits growth in the same culture system (Rappolee et al.,
1992).
Effect of exogenous FGF-4 on proliferation of ICM-
derived cells 
Because FGF-4 was concentrated in the ICM, we next looked
for effects on ICM-derived cells. ICMs were isolated by
removal of the trophectoderm of late-stage (day 4.5 p.c.) blas-
tocysts, then cultured on glass or on fibronectin-coated dishes
with or without FGF-4 (8.7×10−10 M). The total number of
adherent ICM-derived cells was increased by FGF-4 after 3
days of culture in serum-free medium on glass (Fig. 4A). The
increase was confined to outgrowing cells with medium-sized
nuclei that morphologically resembled parietal endoderm and
that stained with parietal endoderm markers such as SPARC
and laminin, but not SSEA-1 (O. Behrendtsen et al., unpub-
lished data). The number of cells with small whorled nuclei,
morphologically resembling ICM cells, was not affected by
FGF-4 (Fig. 4A). Isolated ICMs cultured in serum-free
medium on fibronectin-coated dishes showed a time-dependent
increase in the number of outgrowing cells when stimulated by
FGF-4 (Fig. 4B). The greatest increase occurred on the last day
Fig. 2. FGF-4 polypeptide is expressed in the ICM of the mouse blastocyst. Mouse
embryos were grown in vitro, centrifuged and fixed onto coverslips, and stained for
FGF-4 in the presence (D) or absence (B) of excess FGF-4 ligand. (C,A) Corresponding
phase photomicrographs of the indirect immunofluorescence shown in D and B,
respectively. Whole-mount blastocysts were fixed and stained with normal rabbit serum
(E) or FGF-4 antiserum (F) and developed by means of indirect alkaline phosphatase
chemistry. Large arrowheads indicate FGF-4 staining in the ICM, and small arrowheads
indicate nonspecific staining at junctional complexes in the trophectoderm. 
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of culture; the number of outgrowing cells with medium-sized
nuclei on day 3 (Fig. 4B) was about 4-fold greater than the
number of cells with medium-sized nuclei growing out from
FGF-stimulated ICMs cultured on glass (Fig. 4A). Because the
ICMs were isolated from late-stage blastocysts, no trophecto-
derm cells were formed (Hogan and Tilly, 1978; Handyside,
1978). Thus, outgrowing ICM cells, mostly parietal endoderm
and/or primitive endoderm, appear to be the targets of FGF-4.
Effect of FGF-4 on secretion of 92 kDa gelatinase
and plasminogen activators by ICM cells 
Increases in the secretion of the metalloproteinase 92 kDa
(Mr=92×103) gelatinase and of plasminogen activators are a
hallmark of endoderm differentiation (Adler et al., 1990).
Because FGF-4 appeared to stimulate differentiation of ICM
to parietal endoderm, we analyzed the effect of FGF-4 on
secretion of 92 kDa gelatinase and plasminogen activators by
assaying the conditioned medium by SDS-polyacrylamide
substrate gel zymography (Brenner et al., 1989). ICMs in
groups of 10 were cultured with or without 8.7 ×10−10 M FGF-
4 for 24 hours. As a positive control, ICMs were cultured with
retinoic acid (10−7 M), a known stimulator of endoderm differ-
entiation (Adler et al., 1990). A 4-fold increase in secretion of
92 kDa gelatinase (P<0.002; Student’s t-test) was observed
after a 24-hour incubation of ICMs with FGF-4 or retinoic acid
(Fig. 5A,B). When ICMs were incubated with both FGF-4 and
retinoic acid, the two behaved additively and a significant
increase was seen over ICMs treated with FGF-4 or retinoic
acid alone (P<0.001 and P<0.002, respectively) (Fig. 5A,B).
FGF-4 also increased expression of tissue plasminogen
activator in ICM cells (Fig. 5C), indicating that FGF-4 stimu-
lates parietal endoderm differentiation (Marotti et al., 1982;
Imada et al., 1990).
Expression of FGFR-3 and FGFR-4 mRNA in the
blastocyst 
To determine if receptors for FGF-4 were present, we
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Fig. 3. FGF-4 does not stimulate growth in mouse embryos cultured
from the 2-cell through the blastocyst stage. 2-cell embryos were
cultured in medium alone or with a range of FGF-4 concentrations: 0
(medium alone), 1, 4.3×10−12 M; 2, 4.3×10−11 M; 3, 4.3×10−10 M; 4,
4.3×10−9 M; 5, 4.3×10−8 M; 6, 4.3×10−7 M. Embryos were fixed onto
coverslips and stained with Hoechst 33258, and nuclei were counted.
Bars indicate s.e.m. 
0
10
20
30
40
50
60
N
uc
le
i/I
CM
 O
G
FGF-4 - +  - + - +
Small-
Sized
Nuclei
Medium-
Sized
Nuclei
Large-
Sized
Nuclei
A
43210
0
10
20
30
40
50
60
Days in culture
N
um
be
r o
f c
el
ls 
gr
ow
in
g 
ou
t
FGF-4
Medium
B
N
um
be
r o
f c
el
ls 
gr
ow
in
g 
ou
t
Fig. 4. FGF-4 stimulates ICMs to increase the number of outgrowing
cells with medium-sized nuclei. ICMs were isolated from blastocysts
by immunosurgery. Briefly, blastocysts were incubated with anti-
mouse serum, washed, and exposed to complement. Outer
trophectoderm cells were lysed, and the ICMs were cultured for 3
days with or without 8.7×10−10 M FGF-4 on glass (A) or fibronectin
(B). (A) Embryonic cells were fixed and stained with Hoechst 33258,
and all sizes of nuclei were counted. (B) Embryonic cells were fixed
and stained, and nuclei were counted as in (A) after 1, 2, and 3 days
of culture. In this assay only cells with medium-sized nuclei (parietal
endoderm-like) were counted. Bars indicate s.e.m. 
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examined blastocysts by in situ hybridization. FGFR-4 mRNA
was detected in every cell of the 3.5-day blastocyst (Fig.
6A,C). FGFR-3 mRNA was also expressed in every cell of the
blastocyst, but the expression was less intense than that of
FGFR-4 and was greater in the trophectoderm than in the ICM.
FGFR-1 and -2 were expressed at background levels (data not
shown).
DISCUSSION
Our data show that FGF-4 and FGF-3 mRNA are expressed in
peri-implantation embryos but that only FGF-4 mRNA is
expressed before implantation. FGF-4 mRNA was found at all
stages of preimplantation mouse embryos from 1-cell through
blastocyst, whereas FGF-3 mRNA was not found before
implantation. FGF-4 mRNA was found as a maternal tran-
script, appeared to decrease at the 2-cell stage and was strongly
expressed at the blastocyst stage. FGF-4 mRNA decreases and
FGF-3 mRNA increases immediately after stimulation of
differentiation of embryonal carcinoma cells by retinoic acid
(Velcich et al., 1989; Hebert et al., 1990). We observed that
the expression of FGF-4 polypeptide was limited to the ICM
cells in the blastocyst, in agreement with the expression pattern
of FGF-4 mRNA (Niswander and Martin, 1992).
Seventeen growth factors are expressed in mouse preim-
plantation embryos, and 15 other growth factors are not
expressed (Rappolee and Werb, 1994). The temporal
expression pattern of FGF-4 mRNA resembles that of trans-
forming growth factor (TGF)-α and of PDGF-A chain, which
are expressed as maternal transcripts and as zygotic transcripts
at the blastocyst stage (Rappolee et al., 1988). LIF mRNA is
expressed throughout preimplantation development, whereas
TGF-β and IGF-II are expressed only after the 2-cell stage
(Rappolee et al., 1988, 1992). Unlike IGF-II, TGF-α and
PDGF-A chain polypeptides, which are expressed in every
cell of the mouse blastocyst (Rappolee et al., 1988, 1992),
FGF-4 is expressed only in the ICM. Attenuation of endoge-
nous IGF-II results in a decrease in total cell number in the
cultured blastocyst, without a clear effect on any subpopula-
tion of cells (Rappolee et al., 1992). Because FGF-4 and the
TGF-β family members activin and TGF-β2 are expressed in
subsets of cells in the blastocyst (Rappolee and Werb, 1994),
these growth factors may mediate signaling between cells in
the blastocyst. 
0
2
4
6
8
No
treatment
Retinoic
  Acid
FGF-4 Retinoic
  Acid
    +
 FGF-4
A
m
ou
nt
 9
2 
kD
a 
ge
la
tin
as
e
(re
lat
ive
 un
its
)
S.I.        -             3.9                  4.2             6.3

p (C)                   <0.002           <0.002       <0.001

p (FGF-4+RA)   <0.001           <0.002
B
Fig. 5. FGF-4 stimulates ICM cells to increase their secretion of 92
kDa gelatinase and plasminogen activator. (A) FGF-4 induces
secretion of metalloproteinases by ICM outgrowths as detected by
zymography on SDS-polyacrylamide gelatin gels. (B) Retinoic acid
(10−7 M) or FGF-4 (8.7×10−10 M) stimulates an approximate 4-fold
increase in 92 kDa collagenase, and FGF-4 and retinoic acid together
stimulate an approximate 6-fold increase in 92 kDa collagenase in
outgrowing progeny of ICM cells (S.I.=stimulation index). The
differences between ICM outgrowths treated with one or two stimuli
were significant in relation to the control (no treatment) and to each
other. (C) FGF-4 induces secretion of plasminogen activators by
ICM outgrowths. ICMs were plated singly on spots coated with 20
µg/ml fibronectin in 5 µl drops of serum-free medium in the absence
(lane 1) or presence (lane 2) of 10−8 M FGF-4. The conditioned
medium was collected after 3 days, and 9 µl (from 2 ICMs) was
separated on SDS-polyacrylamide casein-plasminogen gels. The
zymogram was incubated at 37˚C for 52 hours. Standards were
Bowes melanoma tissue plasminogen activator (tPA, 0. 01 U; lane 3)
and low molecular weight urokinase (uPA; lane 4) from mouse
trophoblast cultures. 
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The FGF-4 gene promoter contains a response element for
the octamer binding factor. Oct-4 mRNA is expressed in
mouse oocytes and blastocysts and in human oocytes and blas-
tocysts (Curatola and Basilico, 1990; Scholer et al., 1989a,b;
Scholer, 1991; Abdel-Rahman et al., unpublished data), sug-
gesting a role for Oct-4 in activating the transcription of FGF-
4 in the earliest stages of mouse and human embryos. In the
preimplantation stages of mouse development, Oct-4 and FGF-
4 have temporally and spatially overlapping expression
patterns (this paper; Niswander and Martin, 1992; Scholer,
1991) but, in postimplantation mouse embryos, FGF-4 and
Oct-4 are expressed in distinct regions as well as in overlap-
D. A. Rappolee and others
Fig. 6. mRNA transcripts for receptors for FGF are expressed in every cell of the mouse blastocyst. 3.5 day p.c. blastocysts were flushed from
the uterus and then reinjected into an oviduct for stabilization. Oviducts were fixed, and mRNA for FGFR-4 (A) or FGFR-3 (C) was detected
by in situ hybridization using complementary cRNA-digoxigenin and alkaline phosphatase chemistry. Micrographs in B and D are of the same
sections as A and B, respectively, stained with Hoechst 33258 to show nuclei. ICM (yellow), inner cell mass; TE (blue), trophectoderm; PEnd
(pink), primitive endoderm. The bars in A and B indicate 50 µm. 
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ping regions (Niswander and Martin, 1992; Rosner et al.,
1990). This suggests that Oct-4, a trans-activating factor, is
neither necessary nor sufficient for FGF-4 expression but, in
preimplantation mammalian embryos, it may be an important
regulator of FGF-4 expression.
Unlike FGF-1 and FGF-2, but like the other FGFs, FGF-4
has a leader sequence, is secreted and may have paracrine
effects (Curatola and Basilico, 1990; Delli-Bovi et al., 1987).
Isolated, cultured ICMs responded to FGF-4 with an increase
in the outgrowth of medium-sized cells that morphologically
resembled parietal endoderm cells. Because ICMs were
isolated late in blastocyst development, they were not capable
of producing trophectoderm cells, which might resemble
parietal endoderm (Hogan and Tilly; 1978; Handyside, 1978).
In a separate study, we have definitively identified these cells
as parietal endoderm by their expression of laminin, SPARC,
keratin, vimentin and tissue plasminogen activator (Behrendt-
sen et al., unpublished data). This suggests a paracrine or
autocrine role for FGF-4 produced in the ICM. In the mouse
limb bud, FGF-4 of the apical ectodermal ridge may mediate
a paracrine induction of both progress zone mesenchyme and
the zone of polarizing activity (Niswander and Martin,
1993a,b; Vogel and Tickle, 1993). These data suggest that
FGF-4 produced by the ICM may influence the behavior of
both the parietal endoderm and the delaminating primitive
endoderm.
In mouse the primitive endoderm does not contribute to the
embryo proper, but is crucial for formation of the extraembry-
onic endoderm of the visceral and parietal yolk sacs (Gardner
and Rossant, 1979; Cockroft and Gardner, 1987). Descendants
of the primitive endoderm in mouse are apposite to primitive
ectoderm in the gastrulation-stage mouse and may act like the
endoderm, which is crucial in mesoderm induction at gastru-
lation in frog and chick (Slack, 1991). These data suggest that
the formation of extraembryonic endoderm in mouse is likely
to be important in later induction of mouse mesoderm as well.
In frog, the FGF-4/-6 homologue (XeFGF) is a maternal
mRNA transcript that may be important in mesoderm
induction (Isaacs et al., 1992). FGF-4 induces mesoderm in
explanted frog animal caps (Paterno et al., 1989). The
induction of mesoderm correlates with the expression of
brachyury (Wilkinson et al., 1990), and the mRNA for
brachyury is first expressed after the expression of both FGF-
3 and FGF-4 at day 6 p.c., but before overt mesoderm differ-
entiation during gastrulation at day 7.0 p.c. (Hogan et al.,
1986). Because fate maps of mouse, frog and chick are similar
at gastrulation (Lawson et al., 1991), some common mecha-
nisms may be involved in pregastrulation development in the
three species. ICM-derived FGF-4 may contribute directly to
the formation of primitive endoderm and parietal endoderm or
indirectly to the formation of mesoderm.
We found that mouse embryos cultured from the 2-cell
through the blastocyst stage in the presence of recombinant
FGF-4 did not increase their cell number compared with
embryos grown in medium alone. Other ligands such as IGFs,
insulin and TGF-α which give signals through protein tyrosine
kinase receptors, affect early embryos under similar conditions
(Rappolee et al., 1992; Dardik and Schultz, 1991). This
suggests that FGF-4 may not react mitogenically with both
high-and low-affinity receptors on the apical surface of the tro-
phectoderm. However, FGFR-4 mRNA and syndecan mRNA
are co-expressed with Rex-1 mRNA in both trophectoderm and
ICM, and FGFR-3 mRNA is present in trophectoderm
(Rappolee et al., unpublished data). The lack of response of
trophectoderm may be due to expression of FGF receptors only
on the basal surface of the trophectoderm or to a nonmitogenic
response by the trophectoderm.
Because FGF-4 increases the number of parietal endoderm-
like cells growing out from cultured ICMs, and because
delaminating endoderm expresses both high-and low-affinity
FGF receptors, then ICM, primitive endoderm or parietal
endoderm may be influenced by ICM-derived FGF-4. No
change in growth rate of the ICM has been observed in culture
with FGF-4. This could indicate either that FGF receptors in
the ICM are saturated with endogenous FGF-4 or that the
growth of ICM cells is not significantly affected by FGF.
However, several lines of evidence suggest that ICM-derived
FGF-4 acts upon the ICM. Mutant mouse blastocysts with a
targeted null mutation in the FGF-4 gene give rise to a high
number of empty decidua and blastocyst outgrowths fail to
produce an increase of ICM cells during culture (M. Goldfarb,
personal communication). In our study, the number of cells
growing out from normal cultured ICM increased rapidly, sug-
gesting a rapid response to exogenous FGF-4. All cells in the
blastocyst (ICM, primitive endoderm or trophectoderm)
express mRNA transcripts for both receptors for FGF-4,
FGFR-4 and FGFR-3. All cells in the preimplantation
embryos also express protein for FGFR-4 (Rappolee et al.,
unpublished data). Interestingly, in the time between implan-
tation and gastrulation, when parietal endoderm arises, the
only cell type not expressing FGFR-3 or FGFR-4 is parietal
endoderm (Rappolee et al., unpublished data). Thus, it is
likely the effects of FGF-4 in the ICM outgrowth model are
mediated by cells that are precursors to parietal endoderm.
Undifferentiated F9 cells expressing a dominant negative FGF
receptor have a slowed rate of growth (and nearly half of the
stable lines die during cloning). F9 cells differentiated to
parietal endoderm have a normal rate of growth when express-
ing the dominant negative FGF receptor (Rappolee, unpub-
lished data). Mouse embryos expressing a dominant negative
FGF receptor do not progress beyond the blastocyst stage in
vitro (Rappolee and Patel, unpublished data). It has been
shown that preimplantation mouse embryos cultured at low
density proliferate slowly, but the growth rate can be increased
by adding epidermal growth factor (Paria and Dey, 1990).
Experimental evaluation of the effect of FGF-4 on the growth
of isolated ICMs also required that ICMs be cultured at low
density. Taken together, these data suggest that the endoge-
nous FGF-4 influences the ICM.
We have previously found that as embryonic stem cells dif-
ferentiate to endoderm they begin to secrete 92 kDa gelatinase
(Brenner et al., 1989; Adler et al., 1990; Behrendtsen et al.,
1992). Plasminogen activator expression is also induced with
endoderm differentiation (Marotti et al., 1982; Imada et al.,
1990). ICM cells differentiating in the presence of FGF-4
increased their secretion of 92 kDa gelatinase and tissue plas-
minogen activator. This strengthens the hypothesis that FGF-
4 produced by the ICM may regulate the secretory and behav-
ioral phenotype of endoderm cells. 92 kDa gelatinase has been
implicated in migration and penetration of basement
membranes by cells and is correlated with cell growth (Adler
et al., 1990; Alexander and Werb, 1992; Behrendtsen et al.,
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1992; Behrendtsen et al., unpublished data). Retinoic acid
induces the expression of 92 kDa gelatinase during the
induction of F9 teratocarcinoma-derived parietal endoderm
cells and in cells growing out from cultured ICMs (Adler et
al., 1990; Behrendtsen et al., 1992). The morphology of the
outgrowing cells, the potency of the ICM to produce endoderm
but not trophectoderm, and the induction of these proteinases
indicates that the outgrowing cells induced by FGF-4 are
parietal endoderm.
Although cells of the vegetal half from frog embryos form
endoderm when cultured without the animal cap, there is no
definitive evidence that the endoderm after cortical rotation has
a mesoderm-inducing default state independent of the animal
cap. Similarly, mouse ICM delaminates endoderm, which
requires programming to fulfill its putative roles in acquiring
nutrients and inducing mesoderm. Although this study suggests
a role for ICM-derived FGF-4 in programming endoderm,
effects on ICM or trophectoderm are not precluded. These pos-
sibilities may be investigated by judicious ablation of ICM-
derived FGF-4 or of the FGF signal-receiving mechanisms in
each target cell.
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